upsized

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public OfferingKestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

March 07, 2025 17:30 ET  | Source: Kestra Medical Technologies, Ltd. KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra…

2 months ago
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public OfferingKestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering

March 05, 2025 23:03 ET  | Source: Kestra Medical Technologies, Ltd. KIRKLAND, Wash., March 05, 2025 (GLOBE NEWSWIRE) -- Kestra…

3 months ago
Maze Therapeutics Announces Pricing of Upsized Initial Public OfferingMaze Therapeutics Announces Pricing of Upsized Initial Public Offering

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

January 30, 2025 19:30 ET  | Source: Maze Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) --…

4 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago